Axsome Therapeutics (AXSM) FCF Margin (2022 - 2026)
Axsome Therapeutics recorded quarterly FCF Margin of 10.89% in Q1 2026, down 13.99% quarter-over-quarter from 9.55% in Q4 2025, and up 2510.0% year-over-year from 0.42% in Q1 2025.
Axsome Therapeutics' FCF Margin history runs 5 years deep, the most recent figure standing at 10.89% for Q1 2026.
- In Q1 2026, FCF Margin rose 2510.0% year-over-year to 10.89%; the TTM figure through Mar 2026 stood at 10.02% (up 2783.0% YoY), while the FY2025 annual figure was 14.7%, up 1866.0% from the prior year.
- FCF Margin came in at 10.89% for Q1 2026 at Axsome Therapeutics, down from 9.55% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 0.58% in Q3 2025 to a low of 5246.4% in Q4 2024.
- A 5-year average of 396.3% and a median of 39.22% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin plunged 520394 bps in 2024 and surged 523685 bps in 2025, its largest moves.
- Axsome Therapeutics' FCF Margin stood at 113.84% in 2022, then soared by 63 bps to 42.46% in 2023, then plunged by 12257 bps to 5246.4% in 2024, then surged by 100 bps to 9.55% in 2025, then fell by 14 bps to 10.89% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 10.89%, 9.55%, and 0.58% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -10.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.89% |
| Dec 31, 2025 | -9.55% |
| Sep 30, 2025 | 0.58% |
| Jun 30, 2025 | -21.62% |
| Mar 31, 2025 | -35.99% |
| Dec 31, 2024 | -5,246.40% |
| Sep 30, 2024 | -17.87% |
| Jun 30, 2024 | -34.60% |
| Mar 31, 2024 | -71.42% |
| Dec 31, 2023 | -42.46% |
| Sep 30, 2023 | -93.30% |
| Jun 30, 2023 | -118.81% |
| Mar 31, 2023 | -6.23% |
| Dec 31, 2022 | -113.84% |
| Sep 30, 2022 | -135.49% |
| Jun 30, 2022 | -382.97% |